Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.TH |
First Approval Date01 Nov 2010 |
100 Clinical Results associated with Sevapharma As
0 Patents (Medical) associated with Sevapharma As
100 Deals associated with Sevapharma As
100 Translational Medicine associated with Sevapharma As